Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic > Biocon Sells 1.88% in Syngene

Biocon Sells 1.88% in Syngene

Chemical Weekly 2018-05-31

Bengaluru-based biotech firm, Biocon, has sold 1.88% stake in its research arm, Syngene International, for around Rs. 230-crore. According to a filing in the exchanges, Biocon sold 37,65,574 equity shares amounting to 1.88% of the equity share capital of Syngene through open market sale. Post the transaction, promoter and promoter group stakes in the company was 72.57%. Also, in a separate filing to the exchanges, Syngene said Biocon has sold the shares to achieve minimum public shareholding requirement. Public shareholding was 25.90%. 

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.